Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.65 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | TGFBR1 | P36897 | 2/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.30 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.30 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycerin SCHEMBL23495996 | 0.96 | ALDH1A1 (0.60) | ALDH1A1TSHRLMNATGFBR1THRB | |
| Methacrylic Acid SCHEMBL29080036 | 0.94 | ALDH1A1 (0.58) | ALDH1A1TSHRLMNATGFBR1THRB | |
| Methacrylic Acid SCHEMBL8355193 | 0.94 | ALDH1A1 (0.58) | ALDH1A1TSHRLMNATGFBR1THRB | |
| Glycerin SCHEMBL28643209 | 0.89 | ALDH1A1 (0.52) | ALDH1A1TSHRLMNATGFBR1THRB | |
| SCHEMBL28207390 | 0.88 | ALDH1A1 (0.56) | ALDH1A1TSHRLMNATGFBR1THRB | |
| Propylene Glycol SCHEMBL21836014 | 0.87 | ALDH1A1 (0.65) | ALDH1A1TSHRTGFBR1THRBMGAM | |
| SCHEMBL8731726 | 0.87 | TSHR (0.58) | ALDH1A1TSHRLMNATGFBR1THRB | |
| SCHEMBL28321822 | 0.85 | ALDH1A1 (0.52) | ALDH1A1TSHRTGFBR1THRB | |
| Mannitol SCHEMBL28871183 | 0.83 | ALDH1A1 (0.60) | ALDH1A1TSHRLMNATGFBR1THRB | |
| Propylene Glycol SCHEMBL28979820 | 0.83 | ALDH1A1 (0.60) | ALDH1A1TSHRTGFBR1THRBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160220503-A1 | METHOD FOR MAKING CUSTOMISED NANOPARTICLES, NANOPARTICLES AND USES THEREOF | ETH ZURICH (CH) | 2016-08-04 | — | — | US | claimed |
| US-20140186445-A1 | METHOD FOR MAKING CUSTOMISED NANOPARTICLES, NANOPARTICLES AND USES THEREOF | ETH ZURICH (CH) | 2014-07-03 | — | — | US | claimed |
| EP-2709601-A1 | METHOD FOR MAKING CUSTOMISED NANOPARTICLES, NANOPARTICLES AND USES THEREOF | ETH Zurich (CH) | 2014-03-26 | — | — | EP | claimed |
| CN-103507282-A | Method for manufacturing contact lens and contact lens | CHIANG KUO-CHING | 2014-01-15 | — | — | CN | claimed |
| WO-2012156065-A1 | METHOD FOR MAKING CUSTOMISED NANOPARTICLES, NANOPARTICLES AND USES THEREOF | ETH ZURICH (CH) | 2012-11-22 | — | — | WO | claimed |
| EP-2524690-A1 | Method for making customised nanoparticles, nanoparticles and use thereof | ETH Zurich (CH) | 2012-11-21 | — | — | EP | claimed |
| US-20090200692-A1 | Method for manufacturing a silicone contact lens having a hydrophilic surface | CHANG JAME | 2009-08-13 | — | — | US | claimed |
| CN-110835486-B | Antifouling composition | 佐敦有限公司 | 2022-11-29 | — | — | CN | disclosed |
| CN-109983083-B | Antifouling composition | 佐敦有限公司 | 2021-08-17 | — | — | CN | disclosed |
| CN-110835486-A | Antifouling composition | 佐敦有限公司 | 2020-02-25 | — | — | CN | disclosed |
| CN-105440226-B | Silicon-containing hydrogel contact lens and manufacturing method of silicon-containing hydrogel | 望隼科技股份有限公司 | 2017-10-27 | — | — | CN | disclosed |
| US-9708450-B2 | Silicone hydrogel contact lens and method for manufacturing the same | VIZIONFOCUS INC. (TW) | 2017-07-18 | — | — | US | disclosed |
| CN-106244095-A | Acrylate base adhesive and preparation method thereof | 苏州工业园区莱博特瑞新材料科技有限公司 | 2016-12-21 | — | — | CN | disclosed |
| US-20060111535-A1 | Processes including initiation of polymerization by hydrogen atom donation | GRIDNEV ALEXEI A | 2006-05-25 | — | — | US | disclosed |
| US-7022792-B2 | Initiation of polymerization by hydrogen atom donation | E. I. DUPONT DE NEMOURS AND COMPANY (US) | 2006-04-04 | — | — | US | disclosed |
| WO-2005090414-A1 | INITIATION OF POLYMERIZATION BY HYDROGEN ATOM DONATION | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2005-09-29 | — | — | WO | disclosed |
| US-20050209418-A1 | Initiation of polymerization by hydrogen atom donation | E. I. DU PONT DE NEMOURS AND COMPANY | 2005-09-22 | — | — | US | disclosed |
| EP-0044832-A4 | PRODUCTION OF POLY(POLYISOCYANATE SILICATE)SOLID OR CELLULAR SOLID UTILIZING ALKALI METAL SILICATES. | BLOUNT DAVID H | 1982-07-06 | — | — | EP | disclosed |
| EP-0044832-A1 | PRODUCTION OF POLY(POLYISOCYANATE SILICATE)SOLID OR CELLULAR SOLID UTILIZING ALKALI METAL SILICATES | BLOUNT, David H. (US) | 1982-02-03 | — | — | EP | disclosed |
| WO-1981002300-A1 | PRODUCTION OF POLY(POLYISOCYANATE SILICATE)SOLID OR CELLULAR SOLID UTILIZING ALKALI METAL SILICATES | BLOUNT D | 1981-08-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140186445-A1 | METHOD FOR MAKING CUSTOMISED NANOPARTICLES, NANOPARTICLES AND USES THEREOF | MSN, CD14, SAMM50 | ALDH1A1 2301/4885TSHR 3424/4885LMNA 790/4885 |
| US-20160220503-A1 | METHOD FOR MAKING CUSTOMISED NANOPARTICLES, NANOPARTICLES AND USES THEREOF | MSN, CD14, SAMM50 | ALDH1A1 2301/4885TSHR 3424/4885LMNA 790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.